Physician profile
Mark H Bernstein
NPI 1770795734
$2,082.32
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $264 · 2021: $542 · 2022: $697 · 2023: $266 · 2024: $26.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $465.68 | 2019-2023 | Aristada, Lybalvi |
| Lundbeck LLC | $389.43 | 2019-2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $389.01 | 2020-2024 | Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $362.79 | 2021-2023 | Vraylar |
| Indivior INC. | $126.03 | 2022 | |
| Allergan, INC. | $96.03 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $83.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $79.02 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $49.86 | 2021-2023 | Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.59 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.